- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- monomer
- Ligands
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x 8JN: 1-butyl-3-[(~{E})-3-oxidanylprop-1-enyl]-8-[(1~{R},5~{S})-3-tricyclo[3.3.1.0^{3,7}]nonanyl]-7~{H}-purine-2,6-dione(Non-covalent)
- 3 x CLR: CHOLESTEROL(Non-covalent)
CLR.3: 9 residues within 4Å:- Chain A: F.71, A.81, A.82, G.85, F.88, I.89, Q.172
- Ligands: OLA.9, OLC.29
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:F.71, A:A.81, A:F.88, A:I.89
- Hydrogen bonds: A:A.82, A:Q.172
CLR.4: 8 residues within 4Å:- Chain A: L.352, P.353, I.357, F.360, C.367, S.368, L.374
- Ligands: OLA.7
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.352, A:P.353, A:I.357, A:F.360
- Hydrogen bonds: A:S.368
CLR.5: 11 residues within 4Å:- Chain A: F.191, F.192, L.196, L.352, I.356, C.359, F.360, F.363, C.364
- Ligands: OLA.8, OLC.27
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:F.191, A:F.192, A:L.196, A:L.352, A:I.356, A:F.360, A:F.360, A:F.360, A:F.363, A:F.363
- 21 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
OLA.6: 7 residues within 4Å:- Chain A: V.66, T.74, T.77, F.79
- Ligands: OLA.24, OLA.25, OLC.29
Ligand excluded by PLIPOLA.7: 5 residues within 4Å:- Chain A: H.369, P.371, L.374, L.377
- Ligands: CLR.4
Ligand excluded by PLIPOLA.8: 7 residues within 4Å:- Chain A: L.199, L.203, F.210, A.341, G.345
- Ligands: CLR.5, OLA.18
Ligand excluded by PLIPOLA.9: 5 residues within 4Å:- Chain A: A.82, H.84, G.85
- Ligands: CLR.3, OLA.20
Ligand excluded by PLIPOLA.10: 5 residues within 4Å:- Chain A: L.28, T.384, V.387, V.388, F.391
Ligand excluded by PLIPOLA.11: 7 residues within 4Å:- Chain A: G.14, S.15, V.17, V.21, L.372, Y.376, L.377
Ligand excluded by PLIPOLA.12: 4 residues within 4Å:- Chain A: I.136, A.143
- Ligands: OLA.16, OLA.19
Ligand excluded by PLIPOLA.13: 3 residues within 4Å:- Chain A: L.28, G.32, F.391
Ligand excluded by PLIPOLA.14: 1 residues within 4Å:- Chain A: W.373
Ligand excluded by PLIPOLA.15: 3 residues within 4Å:- Chain A: S.16, T.20, L.23
Ligand excluded by PLIPOLA.16: 7 residues within 4Å:- Chain A: R.129, G.132, I.136, V.139, L.140
- Ligands: OLA.12, OLA.19
Ligand excluded by PLIPOLA.17: 5 residues within 4Å:- Chain A: V.34, C.37, W.38, W.41
- Ligands: OLC.31
Ligand excluded by PLIPOLA.18: 6 residues within 4Å:- Chain A: A.341, I.342, G.345, L.349, L.352
- Ligands: OLA.8
Ligand excluded by PLIPOLA.19: 9 residues within 4Å:- Chain A: H.84, V.139, L.140, A.143, M.149, L.150
- Ligands: OLA.12, OLA.16, OLA.20
Ligand excluded by PLIPOLA.20: 6 residues within 4Å:- Chain A: H.84, F.142, M.149
- Ligands: OLA.9, OLA.19, OLA.21
Ligand excluded by PLIPOLA.21: 7 residues within 4Å:- Chain A: A.131, A.135, V.139, F.142
- Ligands: OLA.20, OLA.23, OLC.30
Ligand excluded by PLIPOLA.22: 5 residues within 4Å:- Chain A: A.106, I.109, V.125, I.133, C.137
Ligand excluded by PLIPOLA.23: 5 residues within 4Å:- Chain A: T.128, A.131, G.132, A.135
- Ligands: OLA.21
Ligand excluded by PLIPOLA.24: 2 residues within 4Å:- Chain A: I.19
- Ligands: OLA.6
Ligand excluded by PLIPOLA.25: 2 residues within 4Å:- Ligands: OLA.6, OLC.29
Ligand excluded by PLIPOLA.26: 2 residues within 4Å:- Chain A: I.392, Y.395
Ligand excluded by PLIP- 5 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.27: 4 residues within 4Å:- Chain A: L.196, F.363
- Ligands: CLR.5, OLC.28
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.196, A:F.363
OLC.28: 5 residues within 4Å:- Chain A: Y.188, L.200, F.362, F.363
- Ligands: OLC.27
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.200
- Hydrogen bonds: A:F.362
OLC.29: 10 residues within 4Å:- Chain A: L.67, P.70, F.71, T.74, F.79, C.80, Q.172
- Ligands: CLR.3, OLA.6, OLA.25
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.67, A:P.70, A:F.71, A:T.74, A:F.79
- Hydrogen bonds: A:Q.172, A:Q.172
OLC.30: 10 residues within 4Å:- Chain A: Y.52, V.55, A.59, L.63, G.127, I.134, W.138, F.142
- Ligands: OLA.21, OLC.31
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:Y.52, A:V.55, A:A.59, A:L.63, A:I.134, A:I.134, A:W.138, A:W.138, A:F.142, A:F.142
OLC.31: 8 residues within 4Å:- Chain A: C.37, W.41, Y.52, V.55, A.59, L.63
- Ligands: OLA.17, OLC.30
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:W.41, A:A.59, A:L.63
- Hydrogen bonds: A:Y.52, A:Y.52
- 1 x TAR: D(-)-TARTARIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cheng, R.K.Y. et al., Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity. Structure (2017)
- Release Date
- 2017-07-26
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562,ADENOSINE RECEPTOR A2A SOLUBLE CYTOCHROME B562 ADENOSINE RECEPTOR A2A,Adenosine receptor A2a: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- monomer
- Ligands
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x 8JN: 1-butyl-3-[(~{E})-3-oxidanylprop-1-enyl]-8-[(1~{R},5~{S})-3-tricyclo[3.3.1.0^{3,7}]nonanyl]-7~{H}-purine-2,6-dione(Non-covalent)
- 3 x CLR: CHOLESTEROL(Non-covalent)
- 21 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
- 5 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 1 x TAR: D(-)-TARTARIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cheng, R.K.Y. et al., Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity. Structure (2017)
- Release Date
- 2017-07-26
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562,ADENOSINE RECEPTOR A2A SOLUBLE CYTOCHROME B562 ADENOSINE RECEPTOR A2A,Adenosine receptor A2a: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.